Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research ConsortiumThe future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task forceLong-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry.Sex-related outcome of atrial fibrillation ablation: Insights from the German Ablation Registry.Pulmonary vein isolation by high intensity focused ultrasoundFirst in-human robotic rotor ablation for atrial fibrillation.Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry.Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry.Topographic distribution of focal left atrial tachycardias defined by electrocardiographic and electrophysiological data.Quality of Life After Transcatheter Aortic Valve Replacement: Prospective Data From GARY (German Aortic Valve Registry).Risk of sudden death after successful accessory atrioventricular pathway ablation in resuscitated patients with Wolff-Parkinson-White syndrome.Long-term outcomes after event-free cardioverter defibrillator implantation: comparison between patients discharged within 24 h and routinely hospitalized patients in the German DEVICE registry.Erythropoietin and VEGF exhibit equal angiogenic potential.Image of the month. Massive right atrial thrombus due to heparin-induced thrombocytopenia type II.Visually-guided balloon catheter ablation of atrial fibrillation: experimental feasibility and first-in-human multicenter clinical outcome.Feasibility of circumferential pulmonary vein isolation using a novel endoscopic ablation system.In vivo left-ventricular contact force analysis: comparison of antegrade transseptal with retrograde transaortic mapping strategies and correlation of impedance and electrical amplitude with contact forceTranscatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of MiNew devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association.Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial.Outcome parameters for trials in atrial fibrillation: executive summary.Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience.Asymptomatic brain lesions following laserballoon-based pulmonary vein isolation.EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HWide circumferential versus individual isolation of pulmonary veins using the endoscopic ablation system.A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design.Balloon Devices for Atrial Fibrillation TherapySubacute Subclinical Brain Infarctions after Transcatheter Aortic Valve Implantation Negatively Impact Cognitive Function in Long-Term Follow-Up.2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.How to determine and assess endpoints for left atrial ablation.Inducibility of atrial tachyarrhythmias after circumferential pulmonary vein isolation in patients with paroxysmal atrial fibrillation: clinical predictor and outcome during follow-up.Left ventricular outflow tract tachycardia including ventricular tachycardia from the aortic cusps and epicardial ventricular tachycardia.Successful trapping of an organized thrombus in a coronary artery aneurysm in myocardial infarction: case report and literature review.Bonus-freeze: benefit or risk? Two-year outcome and procedural comparison of a "bonus-freeze" and "no bonus-freeze" protocol using the second-generation cryoballoon for pulmonary vein isolation.Remote navigation systems in electrophysiology.Balloon catheters for pulmonary vein isolation.
P50
Q26799824-02715A7D-BB6C-4313-84EA-CCD3E1812765Q26860834-C373000E-0575-4AAC-B4D7-2E064C989E76Q27006507-2DC8215F-4CA9-410A-ADDB-5B7151917410Q30313313-0DB655D0-7791-4893-BC7B-61036E98FC14Q30314526-7ADD157A-76C5-40D6-B6FC-DC0B5269A079Q30498734-EDBE0588-361B-4F20-95AD-FDCD715E199FQ30580110-10FC7938-F427-44D3-8507-125BF70DF5A7Q30663685-48B0426A-74C8-409A-AD97-1E41A0DEA67AQ30881747-4A15858D-5A2A-42FC-8CF6-9691C4406E2DQ30912269-E8FCA1A4-1C3F-4496-AA5B-61FBDC7FA3A1Q30981388-62219529-74BB-42EA-A688-E4D970D0152BQ31150792-AD862DD5-D88D-43EC-AB30-54CF5FBB5C38Q33147580-7F9ECFCB-167B-43C6-A553-4D0E205EE6D8Q33167353-6538D44A-0874-49F9-85E0-1413BFF709F1Q33184235-107BAECE-8F48-4A18-B467-3BF92D9F7F97Q33382865-A4CB3482-E595-45E0-8CB0-5A55142B2DE0Q33471968-7243E842-A330-488F-8FD4-CE9D08088093Q33639863-CA086FD1-3A9D-4216-916F-28D534AD8D9EQ34110811-7FD5728B-651F-4D0D-BE16-B6FDD1B61BD0Q34160027-650320E7-9A3C-44B0-8E51-8D25F3E8CBDBQ34387086-EB84362F-D54A-4F69-934C-3C90C6F398AAQ34453706-91EB40E9-677D-4300-916B-C7A96FF06C42Q34583339-DCB12327-7FDC-48DD-B9DC-4C2D3080FED7Q34583344-03D9CDD3-F6CC-489F-8A65-0C9DBAE44251Q34609020-32DC12E7-BC33-42DD-A6BF-E466B315D337Q34656028-6F189909-B908-44BC-AD66-E1B7AAAD2972Q34915364-F5A34404-2384-4CF0-8E76-DF76909309B6Q34981081-653F1ABB-75D7-421A-ACD3-3B727B2F9B3DQ35044455-26431059-7C37-4612-98D1-31E5F4115D1DQ35335708-740D1E38-BB08-4380-95A0-B285568BBB64Q35911657-43C1C1E9-0C4C-4EF6-831F-2019626DB461Q36240596-AA49435E-E307-40FE-803E-205834CB5171Q36594611-82954F6C-30B0-4FDA-9FD2-FD339BF6848BQ36753065-5261C39F-6A17-4D13-9D96-5E27669E0713Q36796404-52649FC4-9CBA-438A-9710-0D60805ECE44Q36819521-7C3DA4F7-10C5-4FF8-9F42-A8234B27F023Q37060926-88279158-421A-4595-BF95-7E927FCCFEF9Q37184432-BEB7CA26-1513-443F-B0D2-1793D02571B0Q37309969-7B4E0EF2-4DD1-4689-953D-F00B934DB76FQ37366505-B54B8681-5BBE-40D7-A8BE-A42875CA3A36
P50
description
Duits cardioloog
@nl
cardiólogu alemán
@ast
deutscher Kardiologe
@de
name
Karl-Heinz Kuck
@ast
Karl-Heinz Kuck
@ca
Karl-Heinz Kuck
@da
Karl-Heinz Kuck
@de
Karl-Heinz Kuck
@en
Karl-Heinz Kuck
@es
Karl-Heinz Kuck
@fr
Karl-Heinz Kuck
@nb
Karl-Heinz Kuck
@nl
Karl-Heinz Kuck
@nn
type
label
Karl-Heinz Kuck
@ast
Karl-Heinz Kuck
@ca
Karl-Heinz Kuck
@da
Karl-Heinz Kuck
@de
Karl-Heinz Kuck
@en
Karl-Heinz Kuck
@es
Karl-Heinz Kuck
@fr
Karl-Heinz Kuck
@nb
Karl-Heinz Kuck
@nl
Karl-Heinz Kuck
@nn
prefLabel
Karl-Heinz Kuck
@ast
Karl-Heinz Kuck
@ca
Karl-Heinz Kuck
@da
Karl-Heinz Kuck
@de
Karl-Heinz Kuck
@en
Karl-Heinz Kuck
@es
Karl-Heinz Kuck
@fr
Karl-Heinz Kuck
@nb
Karl-Heinz Kuck
@nl
Karl-Heinz Kuck
@nn
P214
P227
P244
P106
P19
P21
P213
0000 0000 3089 7200
P214
P227
1122220626
P244
P31
P569
1952-04-20T00:00:00Z
P734
P735
P7859
lccn-n96800241